CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Phase III study (20050181) of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC) pooled safety results
Author
ANDRé T
COLLINS S
+8 more
DUCREUX M
HOTKO Y
LORDICK F
Peeters Marc
PRICE T
SHING M
VERVANTES A
WILSON G
Publication venue
Publication date
01/01/2008
Field of study
No full text
Ghent University Academic Bibliography